Life Sciences Compliance

Understanding Regulatory Compliance for Life Sciences Companies

A guide to managing regulatory requirements across clinical trials, biotech, genomics, and advanced therapies in global markets.

Key regulations

Clinical trials

The EU Clinical Trial Regulation (CTR) establishes requirements for trial authorisation, ethics review, safety reporting, and transparency — replacing the previous directive with a centralised submission process.

GCP compliance

Good Clinical Practice is the international ethical and scientific quality standard for designing, conducting, and reporting clinical trials, ensuring the protection of trial participants and the integrity of data.

Biotech regulations

Biotechnology products — including GMOs, advanced therapy medicinal products (ATMPs), and gene therapies — face specialised regulatory frameworks covering environmental risk, manufacturing, and clinical requirements.

Cross-border submissions

Life sciences companies operating across markets must navigate jurisdiction-specific regulatory requirements, coordinate submission timelines, and maintain consistent documentation across multiple authorities.

Key compliance challenges

•Coordinating clinical trial compliance across multiple countries with differing regulatory requirements, ethics review processes, and safety reporting obligations.
•Navigating specialised regulatory frameworks for advanced therapies (ATMPs, gene therapies) that are still evolving and vary significantly by jurisdiction.
•Managing cross-border submission timelines and ensuring documentation consistency across multiple regulatory authorities.
•Maintaining GCP compliance across complex, multi-site clinical programmes with numerous investigators and monitoring requirements.

Want to stay informed?

Read our latest insights on life sciences regulatory compliance.

Browse Life Sciences articles →